Related Experiment Video
Updated: Jul 10, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Dermatologic therapeutics: thalidomide. A practical guide
M Rosenbach1, Victoria P Werth
1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA 19119, USA.
Dermatologic Therapy
|November 1, 2007
Summary
Thalidomide, initially withdrawn due to birth defects, resurged due to its anti-inflammatory properties. Dermatologists can now safely use thalidomide for various skin conditions.
Area of Science:
- Dermatology
- Pharmacology
- Teratology
Background:
- Thalidomide's initial introduction in the 1950s was followed by widespread use, leading to severe birth defects and market withdrawal in the 1960s.
- A serendipitous discovery during erythema nodosum leprosum treatment revealed thalidomide's potent anti-inflammatory effects, prompting renewed interest in its therapeutic potential.
Purpose of the Study:
- To provide a comprehensive review of thalidomide, covering its history, pharmacology, and mechanisms of action.
- To guide dermatologists on the safe and effective use of thalidomide for cutaneous diseases, including off-label applications.
Main Methods:
- Review of historical data and scientific literature on thalidomide.
- Analysis of pharmacological properties and mechanisms of action.
- Compilation of information on dermatologic applications and safety monitoring.
Main Results:
- Thalidomide, despite its teratogenic history, possesses significant anti-inflammatory properties.
- The drug has emerged as a viable treatment option for several dermatologic conditions.
- Understanding its pharmacology and mechanisms is crucial for safe clinical application.
Conclusions:
- Thalidomide's complex history necessitates careful consideration for its therapeutic use.
- This review equips dermatologists with the knowledge to safely prescribe and monitor thalidomide for cutaneous diseases.
- Further research into thalidomide's applications and safety profile in dermatology is warranted.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...